ITabMed

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of immunotherapy drugs for treatment of cancer. ITabMed is based in Shanghai, China and was founded in 2021. It has raised $20 million.

Last price · $/share

—

Implied valuation

—

Total raised

$20.0M

Last round

—

How much has ITabMed raised?

$20.0Macross 0 recorded rounds

Free account

More of ITabMed with a free account

No card required

Membership and data by Private Market View

ITabMed investors

For fundraisers

Raising for a company like ITabMed?

5 investors have backed ITabMed.

How much has ITabMed raised?: ITabMed has raised $20.0M in total across 0 recorded funding rounds.